Advanced Energy Industries (AEIS) Reiterated at Overweight by Cantor Fitzgerald

Cantor Fitzgerald analyst Matthew Prisco reiterated an Overweight rating and $450.00 price target on Advanced Energy Industries (NASDAQ: AEIS).

The anayst commented, "This was a strong Q for AEIS, with upside across essentially every KPI that matters. Data Center revenues are tracking much better than expected in the back half of the year, supported by market strength, new program wins, and successful supply chain navigation by customers - leading mgmt. to increase its guide for CY26 DC revs to grow +>50% (vs prior +mid-30%s) with a setup for strong growth thereafter bolstered by 2nd wave ramps (800v benefit more meaningful in CY28 timeframe). Semi revs are also tracking higher alongside robust WFE trends - leading mgmt. to increase its guide for 2H26 Semi revs to grow nearly 50% Y/Y, again with strong growth thereafter bolstered by share gains on new product ramps. Further, mgmt. is also working to ship Semi product in line with end-demand here, highlighting the true strength of the biz. And then mgmt. is also seeing healthier demand in Industrial & Medical with positive cyclical dynamics and benefit of new wins ramping. Taken together, mgmt. is now guiding CY26 revs +lowto mid-30%s Y/Y (vs prior low- to mid-20%s), followed by rev growth >20% in CY27. Elsewhere, GMs are coming in better than expected on better volumes/mix, and the company is accelerating Thailand quals on stronger customer demand. Overall, numbers are moving meaningfully higher, and commentary is all trending in the right direction (supporting our bullish view on the name). We reiterate our Overweight rating and $450 price target as our stretch EPS goal of $20 in CY28 remains very much intact (with upside risk bias at this point)."

For an analyst ratings summary and ratings history on Advanced Energy Industries click here. For more ratings news on Advanced Energy Industries click here.

Shares of Advanced Energy Industries closed at $296.38 yesterday.

You May Also Be Interested In

• Viking Holdings (VIK) PT Raised to $82 at Mizuho
• Nuvectis Pharma (NVCT) files $200M mixed shelf
• enVVeno Medical (NVNO) files $100M mixed shelf